You are Trying to View a Premium ArticleDaily News You Can't Find Anywhere Else
Lupin Bets Big on Oncology in AbbVie-Partnership, Could Garner $1 Billion+, an Industrial Info Market Brief
Industry Segment: Pharmaceutical & Biotech | Word Count: 113 Words
Attachment: Lupin Pharma 0119
Indian pharmaceutical company Lupin Limited is eyeing major growth in its portfolio through a Novel Drug Discovery and Development (NDDD) program, focused on oncology, immunology and metabolic disorders
This Premium Article can be purchased individually or as part of a subscription
Subscribe Now! All Fields Required...
- North American Project Spending Index Up 11.05% in February
- Thermo Fisher to Acquire Brammer Bio, an Industrial Info Market Brief
- Where in the World is Big Pharma Investing? An Industrial Info Market Brief
- Pfizer Spending $12 Million in Latin America, an Industrial Info Market Bri...
- Pharma, Research Sectors Warn U.K. of 'Catastrophic' No-Deal Brexit
- Current Economic Indicators
- Free Daily Industrial Articles
- Monthly Industrial Newsletter
- IIR's Disaster Impact Tracker